Mastoparan vs ShK — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Mastoparan is a 14-amino acid amphipathic peptide from the venom of the wasp Vespula lewisii and related species. It directly activates heterotrimeric Gi/Go proteins independently of cell surface receptors, making it a unique pharmacological tool for dissecting G protein-coupled ...
Calculate Mastoparan dose →ShK is a 35-residue peptide toxin from the sea anemone Stichodactyla helianthus. 3 potassium channel (Kd ~11 pM), which is the dominant channel controlling membrane potential in effector memory T cells (TEM cells)....
Calculate ShK dose →| Parameter | Mastoparan | ShK |
|---|---|---|
| Category | Venom Peptide | Venom Peptide |
| Research | Preclinical/Research Tool | Phase 2 |
| Half-Life | < 15 min (plasma) | Hours (disulfide stabilized) |
| Typical Dose | Research only | N/A |
| Frequency | N/A | N/A |
| Route | IV, local (research) | SC injection (research) |
| FDA Status | No approval | Investigational (dalazatide) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.